Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Coloplast A/S CLPBY OTC

Other OTC • Healthcare • Medical - Instruments & Supplies • DK • USD

SharesGrow Score
72/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$14.45
+113.8%

Coloplast A/S (CLPBY) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $6.76. It has a SharesGrow Score of 72/100, indicating a above average investment profile with 4 out of 7 criteria passed.

Analyst consensus target is CLPBY = $14 (+113.8% upside).

Financials: revenue is $26.3B, +5.3%/yr average growth. Net income is $3.4B, growing at -8.3%/yr. Net profit margin is 13% (healthy). Gross margin is 65.1% (-3.7 pp trend).

Balance sheet: total debt is $22.7B against $16.2B equity (Debt-to-Equity (D/E) ratio 1.4, moderate). Current ratio is 1.61 (strong liquidity). Debt-to-assets is 46.8%. Total assets: $48.5B.

Analyst outlook: 3 / 8 analysts rate CLPBY as buy (38%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 40/100 (Partial), Past 100/100 (Pass), Health 83/100 (Pass), Moat 75/100 (Pass), Future 52/100 (Partial), Income 55/100 (Partial).

$14.45
▲ 113.76% Upside
Average Price Target
The 12-month price target for Coloplast A/S is $14.45.

CLPBY SharesGrow Score Overview

72/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 100/100
Valuation — P/E, PEG, Forward PEG
GROWTH 40/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 83/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 75/100
Gross margin is + market cap
FUTURE 52/100
Analyst outlook — as buy
INCOME 55/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — CLPBY

✓
VALUE Pass
100/100
CLPBY trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Analyst consensus target is $14, implying +107.1% from the current price $7. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
40/100
CLPBY: +5.3%/yr revenue is, -8.3%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✓
PAST Pass
100/100
CLPBY: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
✓
HEALTH Pass
83/100
Balance sheet CLPBY: Debt-to-Equity (D/E) ratio 1.4 (moderate), Current ratio is 1.61 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✓
MOAT Pass
75/100
CLPBY: Gross margin is 65.1% (-3.7 pp trend), $15B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 75/100. ≥ 70 = Pass.
View details →
~
FUTURE Partial
52/100
Analyst outlook: 3 / 8 analysts rate CLPBY as buy (38%). Analyst consensus target is $14 (+107.1% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
~
INCOME Partial
55/100
CLPBY: Net profit margin is 13%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range6.53-11.44
Volume22.67K
Avg Volume (30D)661.12K
Market Cap$15.22B
Beta (1Y)0.58
Dividend Yield$0.3600
Share Statistics
EPS (TTM)1.52
Shares Outstanding$2.25B
IPO Date2014-01-13
Employees16,741
CEOLars Soren Rasmussen
Financial Highlights & Ratios
Revenue (TTM)$26.25B
Gross Profit$17.08B
EBITDA$7.85B
Net Income$3.43B
Operating Income$7.14B
Total Cash$948.88M
Total Debt$22.68B
Net Debt$21.74B
Total Assets$48.46B
Price / Earnings (P/E)4.4
Price / Sales (P/S)0.58
Analyst Forecast
1Y Price Target$14.45
Target High$14.45
Target Low$14.45
Upside+113.8%
Rating ConsensusBuy
Analysts Covering8
Buy 38% Hold 38% Sell 25%
Company Info
CountryDK
ExchangeOther OTC
CurrencyUSD
ISINUS19624Y2000

Price Chart

Track all markets on TradingView
CLPBY
Coloplast A/S ↗  ·  Other OTC
Healthcare • Medical - Instruments & Supplies
6.53 52WK RANGE 11.44

People Also View

ESLOY
ESLOY
EssilorLuxottica SA
$120.76
+3.72%
 ESLOF
ESLOF
EssilorLuxottica SA
$239.28
+4.06%
 HOCPY
HOCPY
HOYA Corporation
$187.73
+0.59%
 SAUHY
SAUHY
Straumann Holding AG
$11.16
+3.38%
 SSMXY
SSMXY
Sysmex Corporation
$8.82
+0.68%
 ANSLY
ANSLY
Ansell Limited
$83.53
+0.00%
 CZMWY
CZMWY
Carl Zeiss Meditec AG
$31.85
+3.07%
 CZMWF
CZMWF
Carl Zeiss Meditec AG
$31.83
+3.11%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message